Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
|
Total |
Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Income |
| Balance (in shares) at Dec. 31, 2018 |
|
27,391,290
|
|
|
|
| Beginning Balance at Dec. 31, 2018 |
$ 22,898,000
|
$ 27,000
|
$ 115,450,000
|
$ (92,564,000)
|
$ (15,000)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
| Vesting of restricted stock units (in shares) |
|
116,997
|
|
|
|
| Stock-based compensation |
1,040,000
|
|
1,040,000
|
|
|
| Exercise of warrants (in shares) |
|
140,000
|
|
|
|
| Exercise of warrants |
400,000
|
|
400,000
|
|
|
| Net loss |
(7,137,000)
|
|
|
(7,137,000)
|
|
| Foreign currency translation adjustment, net of tax |
(10,000)
|
|
|
|
(10,000)
|
| Balance (in shares) at Mar. 31, 2019 |
|
27,648,287
|
|
|
|
| Ending Balance at Mar. 31, 2019 |
17,191,000
|
$ 27,000
|
116,890,000
|
(99,701,000)
|
(25,000)
|
| Balance (in shares) at Dec. 31, 2018 |
|
27,391,290
|
|
|
|
| Beginning Balance at Dec. 31, 2018 |
22,898,000
|
$ 27,000
|
115,450,000
|
(92,564,000)
|
(15,000)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
| Net loss |
(22,082,000)
|
|
|
|
|
| Foreign currency translation adjustment, net of tax |
(10,000)
|
|
|
|
|
| Balance (in shares) at Sep. 30, 2019 |
|
32,489,179
|
|
|
|
| Ending Balance at Sep. 30, 2019 |
15,984,000
|
$ 32,000
|
130,623,000
|
(114,646,000)
|
(25,000)
|
| Balance (in shares) at Mar. 31, 2019 |
|
27,648,287
|
|
|
|
| Beginning Balance at Mar. 31, 2019 |
17,191,000
|
$ 27,000
|
116,890,000
|
(99,701,000)
|
(25,000)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
| Vesting of restricted stock units (in shares) |
|
334,774
|
|
|
|
| Stock-based compensation |
1,460,000
|
|
1,460,000
|
|
|
| Exercise of warrants (in shares) |
|
346,809
|
|
|
|
| Exercise of warrants |
987,000
|
$ 1,000
|
986,000
|
|
|
| Net loss |
(7,498,000)
|
|
|
(7,498,000)
|
|
| Foreign currency translation adjustment, net of tax |
16,000
|
|
|
|
16,000
|
| Balance (in shares) at Jun. 30, 2019 |
|
28,329,870
|
|
|
|
| Ending Balance at Jun. 30, 2019 |
12,156,000
|
$ 28,000
|
119,336,000
|
(107,199,000)
|
(9,000)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
| Vesting of restricted stock units (in shares) |
|
198,749
|
|
|
|
| Stock-based compensation |
1,351,000
|
|
1,351,000
|
|
|
| Sales of common stock, net of offering costs (in shares) |
|
3,960,560
|
|
|
|
| Sale of common stock, net of offering costs |
9,940,000
|
$ 4,000
|
9,936,000
|
|
|
| Net loss |
(7,447,000)
|
|
|
(7,447,000)
|
|
| Foreign currency translation adjustment, net of tax |
(16,000)
|
|
|
|
(16,000)
|
| Balance (in shares) at Sep. 30, 2019 |
|
32,489,179
|
|
|
|
| Ending Balance at Sep. 30, 2019 |
$ 15,984,000
|
$ 32,000
|
130,623,000
|
(114,646,000)
|
(25,000)
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
| Sales of common stock, net of offering costs (in shares) |
2,766,798
|
|
|
|
|
| Balance (in shares) at Dec. 31, 2019 |
33,156,246
|
33,156,246
|
|
|
|
| Ending Balance at Dec. 31, 2019 |
$ 9,756,000
|
$ 33,000
|
132,214,000
|
(122,492,000)
|
1,000
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
| Vesting of restricted stock units (in shares) |
|
378,051
|
|
|
|
| Stock-based compensation |
1,338,000
|
|
1,338,000
|
|
|
| Sales of common stock, net of offering costs (in shares) |
|
19,166,667
|
|
|
|
| Sale of common stock, net of offering costs |
26,460,000
|
$ 19,000
|
26,441,000
|
|
|
| Net loss |
(8,005,000)
|
|
|
(8,005,000)
|
|
| Foreign currency translation adjustment, net of tax |
9,000
|
|
|
|
9,000
|
| Balance (in shares) at Mar. 31, 2020 |
|
52,700,964
|
|
|
|
| Ending Balance at Mar. 31, 2020 |
$ 29,558,000
|
$ 52,000
|
159,993,000
|
(130,497,000)
|
10,000
|
| Balance (in shares) at Dec. 31, 2019 |
33,156,246
|
33,156,246
|
|
|
|
| Beginning Balance at Dec. 31, 2019 |
$ 9,756,000
|
$ 33,000
|
132,214,000
|
(122,492,000)
|
1,000
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
| Net loss |
(21,283,000)
|
|
|
|
|
| Foreign currency translation adjustment, net of tax |
$ 44,000
|
|
|
|
|
| Balance (in shares) at Sep. 30, 2020 |
53,396,347
|
53,396,347
|
|
|
|
| Ending Balance at Sep. 30, 2020 |
$ 19,282,000
|
$ 53,000
|
162,959,000
|
(143,775,000)
|
45,000
|
| Balance (in shares) at Mar. 31, 2020 |
|
52,700,964
|
|
|
|
| Beginning Balance at Mar. 31, 2020 |
29,558,000
|
$ 52,000
|
159,993,000
|
(130,497,000)
|
10,000
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
| Vesting of restricted stock units (in shares) |
|
405,077
|
|
|
|
| Vesting of restricted stock units |
1,000
|
$ 1,000
|
|
|
|
| Stock-based compensation |
1,625,000
|
|
1,625,000
|
|
|
| Additional offering costs in connection with February sale of common stock |
(50,000)
|
|
(50,000)
|
|
|
| Exercise of warrants (in shares) |
|
6,640
|
|
|
|
| Net loss |
(7,215,000)
|
|
|
(7,215,000)
|
|
| Foreign currency translation adjustment, net of tax |
8,000
|
|
|
|
8,000
|
| Balance (in shares) at Jun. 30, 2020 |
|
53,112,681
|
|
|
|
| Ending Balance at Jun. 30, 2020 |
23,927,000
|
$ 53,000
|
161,568,000
|
(137,712,000)
|
18,000
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
| Vesting of restricted stock units (in shares) |
|
281,791
|
|
|
|
| Vesting of restricted stock units |
0
|
|
|
|
|
| Stock-based compensation |
1,388,000
|
|
1,388,000
|
|
|
| Exercise of warrants (in shares) |
|
1,875
|
|
|
|
| Exercise of warrants |
3,000
|
|
3,000
|
|
|
| Net loss |
(6,063,000)
|
|
|
(6,063,000)
|
|
| Foreign currency translation adjustment, net of tax |
$ 27,000
|
|
|
|
27,000
|
| Balance (in shares) at Sep. 30, 2020 |
53,396,347
|
53,396,347
|
|
|
|
| Ending Balance at Sep. 30, 2020 |
$ 19,282,000
|
$ 53,000
|
$ 162,959,000
|
$ (143,775,000)
|
$ 45,000
|